Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masanori Onda

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Current Drug Targets|February 10, 2009
Reducing the immunogenicity of protein therapeuticsMasanori Onda
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Recombinant immunotoxins with low endotoxins for clinical and animal studiesMasanori Onda
Immunological Reviews|February 12, 2016
Immunogenicity of therapeutic recombinant immunotoxinsRonit Mazor, Masanori Onda, Ira Pastan
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2019
Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunityMasanori Onda, Kazuto Kobayashi, Ira Pastan
Clinical Orthopaedics and Related Research|January 22, 2005
TP-3 immunotoxins improve antitumor activity in mice with osteosarcomaMasanori Onda, Øyvind S Bruland, Ira Pastan
Bioconjugate Chemistry|March 20, 2003
Mutants of immunotoxin anti-Tac(dsFv)-PE38 with variable number of lysine residues as candidates for site-specific chemical modification. 1. Properties of mutant moleculesMasanori Onda, James J Vincent, Byungkook Lee, et al.
The Journal of Biological Chemistry|October 20, 2004
In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxinMitchell Ho, Robert J Kreitman, Masanori Onda, et al.
Leukemia Research|August 17, 2014
An improved recombinant Fab-immunotoxin targeting CD22 expressing malignanciesTapan K Bera, Masanori Onda, Robert J Kreitman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2015
Bortezomib reduces pre-existing antibodies to recombinant immunotoxins in miceMichael L Manning, Emily Mason-Osann, Masanori Onda, et al.
Leukemia & Lymphoma|April 21, 2011
Immunotoxins with decreased immunogenicity and improved activityIra Pastan, Masanori Onda, John Weldon, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Current Drug Targets|February 10, 2009
Reducing the immunogenicity of protein therapeuticsMasanori Onda
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Recombinant immunotoxins with low endotoxins for clinical and animal studiesMasanori Onda
Immunological Reviews|February 12, 2016
Immunogenicity of therapeutic recombinant immunotoxinsRonit Mazor, Masanori Onda, Ira Pastan
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2019
Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunityMasanori Onda, Kazuto Kobayashi, Ira Pastan
Clinical Orthopaedics and Related Research|January 22, 2005
TP-3 immunotoxins improve antitumor activity in mice with osteosarcomaMasanori Onda, Øyvind S Bruland, Ira Pastan
Bioconjugate Chemistry|March 20, 2003
Mutants of immunotoxin anti-Tac(dsFv)-PE38 with variable number of lysine residues as candidates for site-specific chemical modification. 1. Properties of mutant moleculesMasanori Onda, James J Vincent, Byungkook Lee, et al.
The Journal of Biological Chemistry|October 20, 2004
In vitro antibody evolution targeting germline hot spots to increase activity of an anti-CD22 immunotoxinMitchell Ho, Robert J Kreitman, Masanori Onda, et al.
Leukemia Research|August 17, 2014
An improved recombinant Fab-immunotoxin targeting CD22 expressing malignanciesTapan K Bera, Masanori Onda, Robert J Kreitman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2015
Bortezomib reduces pre-existing antibodies to recombinant immunotoxins in miceMichael L Manning, Emily Mason-Osann, Masanori Onda, et al.
Leukemia & Lymphoma|April 21, 2011
Immunotoxins with decreased immunogenicity and improved activityIra Pastan, Masanori Onda, John Weldon, et al.
Pageof 6